How do harmful chronic myelogenous leukemia stem cells obtain their nutrients?

Medical researchers have found a novel nutrient uptake process that maintains the activity of murine chronic myelogenous leukemia (CML) stem cells. Pharmacological inhibition of nutrient uptake decreased CML stem cell activity. Certain nutrients support CML stem cell activity in vivo, thus pointing towards a potential therapeutic target for CML therapy.

[Read the full article here]

Comments are closed.